يعرض 1 - 3 نتائج من 3 نتيجة بحث عن '"Conjugate technology"', وقت الاستعلام: 0.87s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Pharmacological effects of N-[2-[[2-[2-[(2,6-dichlorophenyl)amino]phenyl]acetyl]oxy]ethyl]hyaluronamide (diclofenac Etalhyaluronate, SI-613), a novel sodium hyaluronate derivative chemically linked with diclofenac

    المؤلفون: Keiji Yoshioka, Tomochika Kisukeda, Ryoji Zuinen, Yosuke Yasuda, Kenji Miyamoto

    المصدر: BMC Musculoskeletal Disorders, Vol 19, Iss 1, Pp 1-12 (2018)

    مصطلحات موضوعية: Osteoarthritis, Hyaluronan, Diclofenac etalhyaluronate, Sustained-release, Conjugate technology, Diseases of the musculoskeletal system, RC925-935

    وصف الملف: electronic resource

    Relation: http://link.springer.com/article/10.1186/s12891-018-2077-8; https://doaj.org/toc/1471-2474

    URL الوصول: https://doaj.org/article/5a5a6c4e90614995930de3fce40c9d82

    Find this article in full text from Springer Verlag. Find this article in full text from ProQuest Full Text Finder
    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Pharmacological effects of N-[2-[[2-[2-[(2,6-dichlorophenyl)amino]phenyl]acetyl]oxy]ethyl]hyaluronamide (diclofenac Etalhyaluronate, SI-613), a novel sodium hyaluronate derivative chemically linked with diclofenac

    المؤلفون: Yoshioka, KeijiAff1, Kisukeda, TomochikaAff1, Zuinen, RyojiAff1, Yasuda, YosukeAff1, Miyamoto, KenjiAff1

    المصدر: BMC Musculoskeletal Disorders. 19(1)

    Find this article in full text from Springer Verlag. Find this article in full text from ProQuest Full Text Finder
    أضف إلى المفضلة
  3. 3
    Pharmacological effects of N-[2-[[2-[2-[(2,6-dichlorophenyl)amino]phenyl]acetyl]oxy]ethyl]hyaluronamide (diclofenac Etalhyaluronate, SI-613), a novel sodium hyaluronate derivative chemically linked with diclofenac

    المؤلفون: Kenji Miyamoto, Ryoji Zuinen, Keiji Yoshioka, Tomochika Kisukeda, Yosuke Yasuda

    المصدر: BMC Musculoskeletal Disorders, Vol 19, Iss 1, Pp 1-12 (2018)
    BMC Musculoskeletal Disorders

    مصطلحات موضوعية: Male, Diclofenac, lcsh:Diseases of the musculoskeletal system, Analgesic, Sodium hyaluronate, Arthritis, Osteoarthritis, Pharmacology, Injections, Intra-Articular, Rats, Sprague-Dawley, Diclofenac etalhyaluronate, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Rheumatology, Pharmacokinetics, Animals, Medicine, Orthopedics and Sports Medicine, 030212 general & internal medicine, Hyaluronic Acid, Hyaluronan, 030203 arthritis & rheumatology, business.industry, Anti-Inflammatory Agents, Non-Steroidal, Diclofenac Sodium, medicine.disease, Arthritis, Experimental, Rats, Treatment Outcome, Knee pain, chemistry, Conjugate technology, Silver Nitrate, Rabbits, medicine.symptom, lcsh:RC925-935, business, Sustained-release, Research Article, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bdb6577f68184dfa19a3a65b020f6ce8
    http://link.springer.com/article/10.1186/s12891-018-2077-8

    Find this article in full text from Springer Verlag. Find this article in full text from ProQuest
    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء